224 related articles for article (PubMed ID: 21542925)
1. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
[TBL] [Abstract][Full Text] [Related]
2. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
Rasmussen SA; Yang Q; Friedman JM
Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
[TBL] [Abstract][Full Text] [Related]
3. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
[TBL] [Abstract][Full Text] [Related]
4. Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
Vasconcelos RAT; Coscarelli PG; Alvarenga RP; Acioly MA
Arq Neuropsiquiatr; 2017 Jun; 75(6):366-371. PubMed ID: 28658406
[TBL] [Abstract][Full Text] [Related]
5. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.
Zöller M; Rembeck B; Akesson HO; Angervall L
Acta Derm Venereol; 1995 Mar; 75(2):136-40. PubMed ID: 7604643
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
Zehou O; Fabre E; Zelek L; Sbidian E; Ortonne N; Banu E; Wolkenstein P; Valeyrie-Allanore L
Orphanet J Rare Dis; 2013 Aug; 8():127. PubMed ID: 23972085
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
[TBL] [Abstract][Full Text] [Related]
8. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.
Evans DG; O'Hara C; Wilding A; Ingham SL; Howard E; Dawson J; Moran A; Scott-Kitching V; Holt F; Huson SM
Eur J Hum Genet; 2011 Nov; 19(11):1187-91. PubMed ID: 21694737
[TBL] [Abstract][Full Text] [Related]
9. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
Friedrich RE; Hartmann M; Mautner VF
Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
[TBL] [Abstract][Full Text] [Related]
10. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
[TBL] [Abstract][Full Text] [Related]
11. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
[TBL] [Abstract][Full Text] [Related]
12. Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors.
Kluwe L; Friedrich RE; Peiper M; Friedman J; Mautner VF
Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517963
[TBL] [Abstract][Full Text] [Related]
13. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
[TBL] [Abstract][Full Text] [Related]
14. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
15. Malignant peripheral nerve sheath tumors in neurofibromatosis 1.
King AA; Debaun MR; Riccardi VM; Gutmann DH
Am J Med Genet; 2000 Aug; 93(5):388-92. PubMed ID: 10951462
[TBL] [Abstract][Full Text] [Related]
16. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
17. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).
Masocco M; Kodra Y; Vichi M; Conti S; Kanieff M; Pace M; Frova L; Taruscio D
Orphanet J Rare Dis; 2011 Mar; 6():11. PubMed ID: 21439034
[TBL] [Abstract][Full Text] [Related]
18. Noncommunicable disease mortality and life expectancy in immigrants to Israel from the former Soviet Union: country of origin compared with host country.
Ott JJ; Paltiel AM; Becher H
Bull World Health Organ; 2009 Jan; 87(1):20-9. PubMed ID: 19197401
[TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
20. Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years.
Ingham S; Huson SM; Moran A; Wylie J; Leahy M; Evans DG
Eur J Cancer; 2011 Dec; 47(18):2723-8. PubMed ID: 21700447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
